Latest Breaking News On - Alban dufumier - Page 2 : comparemela.com

OPM Announces Its 2022 Annual Results and Provides an Update on Its Clinical Developments

OPM Announces Its 2022 Annual Results and Provides an Update on Its Clinical Developments
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Karine lignelPhilippe genneJan hoflackArthur rouillMathilde bohin alban dufumierOncodesign servicesResearch tax creditTransition service agreementPrecision medicineChief executive officerOncodesign biotechnologyEuronext growthArtificial intelligenceMonday aprilOrdinary general meetingOncodesign precision medicine

Oncodesign Precision Medicine Announces the Initiation of Phase I of its RIPK2 Inhibitor ODS-101, a New Therapeutic Agent for IBD

Oncodesign Precision Medicine Announces the Initiation of Phase I of its RIPK2 Inhibitor ODS-101, a New Therapeutic Agent for IBD
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France generalArthur rouillMathilde bohin alban dufumierPhilippe genneJan hoflackWall streetPrecision medicineOncodesign precisionBowel diseaseChief scientific officerOncodesign precision medicineAlban dufumier

Oncodesign Precision Medicine Announces the Initiation of Phase I of its RIPK2 Inhibitor ODS-101, a

First-in-Man study of ODS-101 in healthy volunteersDIJON, France (BUSINESS WIRE) Regulatory News:Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Mnemonic: ALOPM) (Paris:ALOPM), a clinical stage biopharmaceutical company specializing in precision medicine for the treatment of resistant and metastatic cance.

France generalArthur rouillMathilde bohin alban dufumierPhilippe genneJan hoflackRegulatory newsPrecision medicineOncodesign precisionBowel diseaseChief scientific officerOncodesign precision medicineAlban dufumier